Few Chinese preparations carry the reputation of Angong Niuhuang Wan, and few present as many regulatory obstacles at the border. Manufactured by Beijing Tong Ren Tang Technology Development in a single-pill 3g presentation, this item is bought as much for its documentation package as for the pill itself, because ingredient declarations determine whether a shipment clears at all.
The formula belongs to the orifice-opening category in classical practice, traditionally applied where high fever is accompanied by clouded consciousness. Its composition combines aromatic and cooling components, historically including bovine or synthetic bezoar, buffalo horn concentrate, musk or a synthetic substitute, pearl powder, cinnabar, realgar, borneol, curcuma, coptis, scutellaria and gardenia. Two of those entries dictate compliance workload. Cinnabar contributes mercury sulphide and realgar contributes arsenic sulphide, so heavy-metal limits in the destination market decide admissibility. Musk and horn-derived material raise wildlife-trade questions even when synthetic or farmed substitutes are used.
Domestic labelling covers high fever with impaired consciousness, convulsive presentations, and use during acute cerebrovascular events where the traditional pattern is judged to apply. Overseas, the same pill is rarely registered as a medicine. It usually enters as a registered traditional medicine under a country-specific scheme, or not at all, which is why the intended regulatory route must be settled before an order is placed rather than after.
The traditional adult dose is one 3g pill taken orally, up to once daily, with paediatric use reduced by age and supervised. Pills are chewed or dissolved in warm water when swallowing is impaired. Use is short-term and acute, not maintenance, and the mineral content makes prolonged or repeated administration inappropriate without professional oversight.
Store sealed at room temperature away from moisture and light; the wax-sealed presentation protects volatile aromatics and should stay intact until dispensing. For buyers, assemble the compliance file first: manufacturing licence, GMP certificate, full quantitative ingredient declaration, heavy-metal test results against the destination limit, and CITES or equivalent permits covering any animal-derived component. Confirm which substitutes the batch actually uses, since synthetic musk and farmed alternatives change the permit path materially.
Q: Which ingredient most often blocks customs clearance? Cinnabar and realgar. Mercury and arsenic limits in the importing market are usually stricter than the traditional formula assumes, so heavy-metal certificates are decisive.
Q: Does a synthetic musk substitute remove the wildlife-permit requirement? It reduces it but rarely eliminates paperwork. Authorities generally still want written confirmation of the substitute plus batch-level declarations.
Q: Can this pill be marketed as a dietary supplement to simplify entry? No. The claimed use and mineral content place it outside supplement frameworks in most jurisdictions; misclassification risks seizure.
Q: What batch documentation should accompany each carton? Batch number, manufacturing and expiry dates, quantitative ingredient declaration, heavy-metal assay, and the manufacturer's GMP certificate reference.
Few Chinese preparations carry the reputation of Angong Niuhuang Wan, and few present as many regulatory obstacles at the border. Manufactured by Beijing Tong Ren Tang Technology Development in a single-pill 3g presentation, this item is bought as much for its documentation package as for the pill itself, because ingredient declarations determine whether a shipment clears at all.
The formula belongs to the orifice-opening category in classical practice, traditionally applied where high fever is accompanied by clouded consciousness. Its composition combines aromatic and cooling components, historically including bovine or synthetic bezoar, buffalo horn concentrate, musk or a synthetic substitute, pearl powder, cinnabar, realgar, borneol, curcuma, coptis, scutellaria and gardenia. Two of those entries dictate compliance workload. Cinnabar contributes mercury sulphide and realgar contributes arsenic sulphide, so heavy-metal limits in the destination market decide admissibility. Musk and horn-derived material raise wildlife-trade questions even when synthetic or farmed substitutes are used.
Domestic labelling covers high fever with impaired consciousness, convulsive presentations, and use during acute cerebrovascular events where the traditional pattern is judged to apply. Overseas, the same pill is rarely registered as a medicine. It usually enters as a registered traditional medicine under a country-specific scheme, or not at all, which is why the intended regulatory route must be settled before an order is placed rather than after.
The traditional adult dose is one 3g pill taken orally, up to once daily, with paediatric use reduced by age and supervised. Pills are chewed or dissolved in warm water when swallowing is impaired. Use is short-term and acute, not maintenance, and the mineral content makes prolonged or repeated administration inappropriate without professional oversight.
Store sealed at room temperature away from moisture and light; the wax-sealed presentation protects volatile aromatics and should stay intact until dispensing. For buyers, assemble the compliance file first: manufacturing licence, GMP certificate, full quantitative ingredient declaration, heavy-metal test results against the destination limit, and CITES or equivalent permits covering any animal-derived component. Confirm which substitutes the batch actually uses, since synthetic musk and farmed alternatives change the permit path materially.
Q: Which ingredient most often blocks customs clearance? Cinnabar and realgar. Mercury and arsenic limits in the importing market are usually stricter than the traditional formula assumes, so heavy-metal certificates are decisive.
Q: Does a synthetic musk substitute remove the wildlife-permit requirement? It reduces it but rarely eliminates paperwork. Authorities generally still want written confirmation of the substitute plus batch-level declarations.
Q: Can this pill be marketed as a dietary supplement to simplify entry? No. The claimed use and mineral content place it outside supplement frameworks in most jurisdictions; misclassification risks seizure.
Q: What batch documentation should accompany each carton? Batch number, manufacturing and expiry dates, quantitative ingredient declaration, heavy-metal assay, and the manufacturer's GMP certificate reference.
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
العربية
हिन्दी
Türkçe
indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski
